Patent Assignment
Reel/Frame 040904/0482
Assignment of Assignor's Interest
Recorded: 2017-01-09
Pages: 9
Assignors
AKIREDDY, SRINIVASA RAO
Executed: 2011-05-16
BHATTI, BALWINDER SINGH
Executed: 2011-05-18
CUTHBERTSON, TIMOTHY J.
Executed: 2011-05-16
DULL, GARY MAURICE
Executed: 2011-05-16
MILLER, CRAIG HARRISON
Executed: 2011-06-02
MITCHENER, JOSEPH PIKE, JR
Executed: 2011-05-16
MUNOZ, JULIO A.
Executed: 2011-05-26
OTTEN, PIETER ALBERT
Executed: 2011-05-18
Assignee
TARGACEPT, INC.
200 EAST FIRST STREET, SUITE 300, WINSTON SALEM, NORTH CAROLINA, 27101
Covered Properties
(2)
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3YLVINYL)Pyrimidine
Synthesis and Novel Salt Forms of (R)-5-((E)-2-Pyrrolidin-3YLVINYL)Pyrimidine
Application:
14/832,030 →
Publication:
US 2016/0046609
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 13, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041043/0769 →
Change of Name
Jan 13, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041044/0211 →
Patent Security Agreement
Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Corrective Assignment to Correct the the Conveying Party Execution Date Previously Recorded at Reel: 041044 Frame: 0211. Assignor(S) Hereby Confirms the Assignment.
Oct 26, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 057923/0518 →
Release of Security Interest
Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →